Back to Search
IAN KROP, MD PHD
MD PHD
Medical Oncology Physician
NPI: 1033187455IndividualAccepts Medicare
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1996
Research & Publications (17)
Mechanisms of trastuzumab resistance in breast cancer.
PMID 19275526·Anticancer Agents Med Chem·2009
6-review
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen.
PMID 19214387·Invest New Drugs·2009
3-trial
Ten years of HER2-directed therapy: still questions after all these years.
PMID 18463974·Breast Cancer Res Treat·2009
8-other
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
PMID 18180460·J Clin Oncol·2008
3-trial
Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression.
PMID 18765527·Clin Cancer Res·2008
8-other
Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?
PMID 17640031·J Surg Oncol·2007
3-trial
Chemokine signaling in gliomas: prognostic factor, therapeutic target or both?
PMID 16931903·Cancer Biol Ther·2006
8-other
A putative role for psoriasin in breast tumor progression.
PMID 16357139·Cancer Res·2005
7-preclinical
HIN-1, an inhibitor of cell growth, invasion, and AKT activation.
PMID 16266985·Cancer Res·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, MAYER 220B
BOSTON, MA 02115 - Phone
- (617) 632-3427
Quick Facts
- NPI
- 1033187455
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 30
- Publications
- 17
Are you this provider?
Claim Your Profile